• 10 Oct 2008
  • Guy Brenchley

Preparation of 5-cyano-4-(pyrrolo[2,3-b]pyridin-3-yl)pyrimidines as polo-like kinase (PLK) inhibitors

  • Patents

Resources & Insights

  • 9 Mar 2026
  • Rob Crook
High Throughput Experimentation: Fully Integrated or Modular System?
  • Chemical Development
  • High Throughput Experimentation
  • Process R&D
  • Thought Leaders
  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders
  • 22 Jan 2026
  • Loïc Roux
Designing Therapeutic Oligonucleotides – A Practical Framework from Biology to Sequence Selection
  • Design-Make-Test
  • DMTA
  • Oligonucleotides
  • Thought Leaders